| PRESENTER NAME | POSTER TITLE | Day | POSTER NUMBER |
| Isaiah Kicknosway | The Effect of Cannabis on Indigenous People | Day 1, May 28 | 1 |
| Wanting Ding | Perspectives from Developmental Pediatricians on Medical Cannabis in Children With Autism | Day 1, May 28 | 2 |
| Cinthya Moshtagh | Breastmilk Immunity and Cannabis: Investigating the Effect of Maternal Cannabis Consumption on Secretory IgA & IgM Levels in Breastmilk | Day 1, May 28 | 3 |
| Leticia Hernandez Galan | Impact of Cannabis Consumption on Prolactin Levels and Potential Effects on Breast Milk Production | Day 1, May 28 | 4 |
| Yiye Wang | The Impact of Gestational Cannabis Smoke Exposure on Maternal Mammary Gland Development: A Mouse Model | Day 1, May 28 | 5 |
| Maya Thomas | The Influence of Maternal Cannabis Use on Dietary Patterns | Day 1, May 28 | 6 |
| Chiara Fricano | Bridging the Gap: Early Lessons From the Feasibility Study to Measure Neurodevelopmental Outcomes in Babies Exposed to Cannabis in Utero in Hamilton (FINCH) | Day 1, May 28 | 7 |
| Sierra D'Amico | Influence of Prenatal High-Δ9-THC Cannabis Smoke Exposure on the Developing Gut-Brain Axis | Day 1, May 28 | 8 |
| Maqdis Ali | Chronic THC induces pro-inflammatory microglial activation and alters synaptic density in adolescent rat nucleus accumbens | Day 1, May 28 | 9 |
| Cassie Cote | Investigating the Relationship Between Cannabis and Synaptic Density in Youth: A [18F]SynVesT-1 PET Imaging Study | Day 1, May 28 | 10 |
| Heidi Xu | Investigating neuroprotective effects of glucagon-like peptide-1 receptor agonists following adolescent cannabis exposure | Day 1, May 28 | 11 |
| Peter Najdzionek | Does Persistent Cannabis Use Alter Brain Structure? A Systematic Review | Day 1, May 28 | 12 |
| Isabella Hotston | Cannabis Use, Childhood Trauma and Stress: A Latent Class Analysis of Risk Profiles Among Young Adults | Day 1, May 28 | 13 |
| Raha Razaghi | Examining the Association Between Social Support and Cannabis Use Frequency and Consequences in Canadian Emerging Adults | Day 1, May 28 | 14 |
| Alysha Sultan | Correlates of Cannabis Use and Cannabis Use Disorder Among Youth With and At-Risk for Bipolar Disorder | Day 1, May 28 | 15 |
| Erin MacDougall | PTSD-Related Anticipatory Cannabis Craving Through Coping Motives: What is the Moderating Role of Anxiety Sensitivity? | Day 1, May 28 | 16 |
| Audrey Parker | PTSD Symptom Clusters and Cannabis-Related Problems: The Moderating Role of Cannabis Outcome Expectancies | Day 1, May 28 | 17 |
| Hanan Idd | Brain Fatty Acid Amide Hydrolase Levels and Compulsions in Obsessive-Compulsive Disorder: Preliminary Results from a Positron Emission Tomorgraphy (PET) Study with [11C] CURB | Day 1, May 28 | 18 |
| Lola Zovko | Effects of Endocannabinoid Modulation in an Acute Mouse Model of Parkinson's Disease | Day 1, May 28 | 19 |
| Emily Dye | Cannabis Use and Stress: Cumulative to State-Based | Day 1, May 28 | 20 |
| Mohammed Sarikahya | Chronic Social Stress on Fear Memory Generalization | Day 1, May 28 | 21 |
| Jeffery Jones | Divergent Dorsolateral Prefrontal Cortex Responses to Cognitive Fatigue in Regular Cannabis Users and Non-Users: A Pilot FNIRS Study | Day 1, May 28 | 23 |
| Qinmeng (Rebecca) Yang | Exploring Neural Mediators in the Relationship between Cannabis and Cognition | Day 1, May 28 | 24 |
| Hannah Nicholson | Vapour Exposure to Cannabis Strains Creates Different Levels of THC Discriminative Stimulus Effects in Rats | Day 1, May 28 | 25 |
| Mahmoud Elsayed | Neural Signatures of Cannabis Use: Resting-State EEG Study | Day 1, May 28 | 26 |
| Christine Wickens | Testing Validity of the Standardized Field Sobriety Test (SFST) to Detect Presence of and Impairment by Cannabis and or Alcohol: A Randomized Clinical Trial | Day 1, May 28 | 27 |
| Sampson Zhao | The use of THC cutoff levels in blood and oral fluid for detecting impairment in frequent cannabis users who smoked cannabis the “evening before” | Day 1, May 28 | 28 |
| Patricia Di Ciano | Time Course of Changes in Driving After Use of Smoked Cannabis | Day 1, May 28 | 29 |
| Paulina Antwi | Dose-Dependent Effects of Cannabis Edibles on Simulated Driving Performance | Day 1, May 28 | 30 |
| Brian Yang | Improving Pain Disability in Chronic Pain Patients with Oral Cannabinoids: A Pilot Randomized Control Trial | Day 2, May 29 | 1 |
| Kim Madden | Patient Perceptions on the Use of Cannabis for Treating Musculoskeletal Pain Post-Legalization: The POSIT-2 survey | Day 2, May 29 | 2 |
| Haley Vecchiarelli | Sex Differences in Endocannabinoid System Gene Expression in the Anterior Cingulate Cortex and Basolateral Amygdala Following Inflammatory and Neuropathic Pain | Day 2, May 29 | 3 |
| Sarah Paleczny | A Longitudinal, Population-Based Analysis of Burn Injuries Across Canada Pre- and Post-Recreational Cannabis Legalization | Day 2, May 29 | 4 |
| Madison Hunt | Beyond the Like Button: Sentiment and Thematic Analysis of Cannabis Conversations Within YouTube Comments | Day 2, May 29 | 5 |
| Lauren Winfield-Ward | Psychometric Validation of the McMaster Cough Severity Questionnaire in Community Participants With and Without Cannabis Use | Day 2, May 29 | 6 |
| Lauren Winfield-Ward | What Changed After Cannabis Legalization? A Systematic Review of Outcomes in Canada | Day 2, May 29 | 7 |
| Amanda Doggett | A Mixed-Methods Analysis of Public Opinions Surrounding Canadian Cannabis Legalization Five Years Post-Implementation | Day 2, May 29 | 8 |
| Erica Li | A Longitudinal Comparison of Public Attitudes Toward Psilocybin and Cannabis: A Prospective Cohort Study (2023–2025) | Day 2, May 29 | 9 |
| Adam Levitan | Recreational Cannabis Legalization and Fall-Related Healthcare Utilization: Surveillance of National Trends in Canada (2006-2024) | Day 2, May 29 | 10 |
| Kyra Farrelly | Simultaneous Use of Cannabis With Other Drugs: Identifying Latent Classes in a Population Survey of Canadians | Day 2, May 29 | 11 |
| Erin Leigh Courtice | Assessing the Predictive and Discriminant Validity of the Impaired Control Scale - Cannabis in an Intensive Longitudinal Study | Day 2, May 29 | 12 |
| Shreya Sharma | Effects of Extended Cannabis Abstinence on Motivational Outcomes in Populations With Co-Morbid Major Depressive Disorder and Cannabis Use Disorder | Day 2, May 29 | 13 |
| Maryam Sorkhou | Symptom Reductions Following 28 Days of Cannabis Abstinence in Patients with Major Depression and Cannabis Use Disorder | Day 2, May 29 | 14 |
| Nicholas Murray | Investigating Automatic Attentional Biases Underlying PTSD-CUD Co-Occurrence | Day 2, May 29 | 15 |
| Anna Mouzenian | Digital Biomarkers Using Wearable Technology and Their Associations With Alcohol and Cannabis Use Disorder Outcomes | Day 2, May 29 | 16 |
| Ayla Sadeghi | Cannabis Use During an Intensive Virtual Treatment Program for Alcohol Use Disorder | Day 2, May 29 | 17 |
| Shelby Prokop-Millar | Relative Spectral Power as a Candidate Biomarker of Cannabis Use Disorder | Day 2, May 29 | 18 |
| Dhvani Mehta | Depressive Symptom Changes in a rTMS Trial for Cannabis Use Disorder | Day 2, May 29 | 19 |
| Tanya Lazor | Electronic Behavioural Economics Interventions: A Promising Intervention for Mitigation of Cannabis Use | Day 2, May 29 | 20 |
| Samuel Boctor | Associations With Higher Insight in Problematic Cannabis Use: A Secondary Analysis of the Canadian Community Health Survey | Day 2, May 29 | 21 |
| Carly McIntyre-Wood | Biological vs. Self‑Report Measures of Cannabis Use: Convergent Validity and Associations with Negative Respiratory Outcomes and Pathological Cannabis Demand | Day 2, May 29 | 23 |
| Nadia Milad | Chronic inhaled cannabis use affects respiratory symptoms: comparison with cigarette smoking in an observational cohort study | Day 2, May 29 | 24 |
| Nadia Milad | Heavy Cannabis Smoking Worsens Lung Function and Respiratory Symptoms in a Case-Control Study | Day 2, May 29 | 25 |
| Riley Brown | Pharmacological Study of Cannabichromene and Cannabigerol at the Serotonin 1A (5-HT1A) and Adenosine 2A (A2A) Receptors | Day 2, May 29 | 26 |
| Samuel Ugulini | CBD Exposure Impairs Mechanisms of Glucagon Trafficking and Secretion in Pancreatic Alpha Cells | Day 2, May 29 | 27 |
| Kesavan Arunachalam | Novel Stereoisomeric Cannabidiol Analogues: Synthesis and CB2 Receptor Activity | Day 2, May 29 | 28 |
| Ben Cleary | Exploring Total THC and Total Terpene Variability in Greenhouse and Indoor Cultivated Dried Cannabis | Day 2, May 29 | 29 |
| Brian Yang | Using Real-World Evidence to Inform Indication-Specific Medical Cannabis Use | Day 2, May 29 | 30 |
